Advances in Multimodal AI: de-risking drug development from discovery to CDx
LIVE PANEL featuring speakers from Amgen, Regeneron, & Modella AI / AstraZeneca The latest generation of cancer therapies, including antibody-drug conjugates and bispecifics, is testing the limits of biomarker strategies, and success depends on far more than target expression at the cell. The tumor microenvironment, spatial biology and cancer cells morphological changes matter just [...]

